| The impact of telerheumatology and COVID-19 on outcomes in a tertiary rheumatology service: a retrospective audit W Zhu, T De Silva, L Eades, S Morton, S Ayoub, E Morand, A Antony Rheumatology 60 (7), 3478-3480, 2021 | 13 | 2021 |
| Breaking the chain of transmission within a tertiary health service: an approach to contact tracing during the COVID-19 pandemic RL Stuart, W Zhu, EF Morand, A Stripp Infection, Disease & Health 26 (2), 118-122, 2021 | 11 | 2021 |
| GILZ regulates the expression of pro-inflammatory cytokines and protects against end-organ damage in a model of lupus C Nataraja, W Dankers, J Flynn, JPW Lee, W Zhu, FB Vincent, LJ Gearing, ... Frontiers in immunology 12, 652800, 2021 | 11 | 2021 |
| GILZ regulates type I interferon release and sequesters STAT1 C Nataraja, J Flynn, W Dankers, M Northcott, W Zhu, R Sherlock, ... Journal of autoimmunity 131, 102858, 2022 | 7 | 2022 |
| AB1576 PERICORONARY ADIPOSE TISSUE (PCAT) ATTENUATION IS ASSOCIATED WITH INFLAMMATORY RHEUMATIC DISEASES (IMD): A RETROSPECTIVE CROSS-SECTIONAL ANALYSIS W Zhu, V Goel, A Antony, N Nerlekar Annals of the Rheumatic Diseases 82 (Suppl 1), 2021-2021, 2023 | | 2023 |
| The evolving demographics of participants in psoriatic arthritis phase III randomised controlled trials of b/tsDMARDs: A systematic review W Zhu, S Ayoub, E Morand, W Tillett, A Antony Seminars in Arthritis and Rheumatism 60, 152175, 2023 | | 2023 |
| The Evolving Demographic of Patients Recruited to Phase III Randomised Controlled Trials of Biologic/Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic … W Zhu, S Ayoub, E Morand, W Tillett, A Antony INTERNAL MEDICINE JOURNAL 52, 34-34, 2022 | | 2022 |
| POS1189 THE IMPACT OF TELEMEDICINE AND COVID-19 ON A TERTIARY RHEUMATOLOGY SERVICE: A RETROSPECTIVE AUDIT W Zhu, T De Silva, L Eades, S Morton, S Ayoub, EF Morand, A Antony Annals of the Rheumatic Diseases 80 (Suppl 1), 876-877, 2021 | | 2021 |
| Balancing Strategies: GC and GILZ Axis C Nataraja, W Zhu, W Dankers, SA Jones Pathogenesis of Systemic Lupus Erythematosus: Insights from Translational …, 2021 | | 2021 |
| The impact of telemedicine and COVID-19 on a tertiary rheumatology service: A retrospective audit W Zhu, T De Silva, L Eades, S Morton, S Ayoub, E Morand, A Antony Internal Medicine Journal, 8-8, 2021 | | 2021 |
| The Glucocorticoid-Induced Protein GILZ Represent a Checkpoint in the IFN Program in SLE E Morand, C Nataraja, M Northcott, W Dankers, J Flynn, W Zhu, T Bennett, ... ARTHRITIS & RHEUMATOLOGY 71, 2019 | | 2019 |
